证监会最新回应！

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has completed the handling of 424 proposals and suggestions from the 2024 National Two Sessions, focusing on enhancing the capital market's support for the real economy and technological innovation [1][4]. Group 1: Support for Technological Innovation - CSRC emphasizes the importance of providing precise financial support for the entire lifecycle of technology innovation industries, encouraging private equity funds to increase financing support for the real economy [3][4]. - Since the establishment of the Sci-Tech Innovation Board in 2019, over 570 companies in sectors like integrated circuits and biomedicine have been listed, creating a cluster effect for "hard technology" [3]. - The CSRC aims to build a bond financing support system for technology innovation enterprises, facilitating their access to capital markets [4][5]. Group 2: Mergers and Acquisitions (M&A) Reform - The CSRC supports high-quality mergers and acquisitions by listed companies as a key measure to enhance the real economy and promote technological innovation [7]. - Recent reforms include the implementation of a restructuring registration system and the introduction of targeted convertible bond restructuring rules to stimulate market activity [7][8]. - Future efforts will focus on deepening market-oriented reforms in M&A, including establishing a "green channel" for technology enterprises [8]. Group 3: Development of the Beijing Stock Exchange - The CSRC is committed to enhancing the quality of listed companies on the Beijing Stock Exchange (BSE) and improving regulatory effectiveness [9][10]. - Plans include optimizing the listing process, enhancing investor structure, and increasing the attractiveness of the BSE to long-term capital [10]. - The CSRC aims to position the BSE as a primary platform for innovative small and medium-sized enterprises [10]. Group 4: Financial Market Connectivity - The CSRC is focused on optimizing and expanding the financial market connectivity between mainland China and Hong Kong, enhancing cross-border investment opportunities [14][15]. - Initiatives include improving existing mechanisms like Stock Connect and Bond Connect, and exploring the feasibility of Hong Kong companies listing in mainland markets [14][15]. - The CSRC aims to support the development of Real Estate Investment Trusts (REITs) and facilitate their cross-border connectivity [13][14]. Group 5: Support for Traditional Medicine and Biopharmaceuticals - The CSRC plans to support the listing and financing of qualified traditional medicine and biopharmaceutical companies, enhancing their market presence [15]. - Efforts will include optimizing the market environment and improving the quality of listed companies in these sectors [15].